The weekly litigation news digest is live. Subscribe now

IP Verse

Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction - EP2916856

The patent EP2916856 was granted to Palatin on Oct 18, 2023. The application was originally filed on Nov 5, 2013 under application number EP13851014A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2916856

PALATIN
Application Number
EP13851014A
Filing Date
Nov 5, 2013
Status
Patent Maintained As Amended
Sep 15, 2023
Publication Date
Oct 18, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSJun 18, 2019HAMM & WITTKOPPADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2005222014
INTERNATIONAL-SEARCH-REPORTUS2011065652
INTERNATIONAL-SEARCH-REPORTUS6794489
INTERNATIONAL-SEARCH-REPORTWO2009151714
OPPOSITIONUS6794489
OPPOSITIONUS7022674
SEARCHWO2011060352

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents